comparemela.com

Latest Breaking News On - Evolent health inc - Page 4 : comparemela.com

In-Depth Examination Of 6 Analyst Recommendations For Evolent Health

Evolent Health (NYSE:EVH) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bear.

Jeff-jones
Constantine-davides
Canaccord-genuity
Daniel-grosslight
Richard-close
Anne-samuel
Unveiling-the-story-behind-evolent-health
Evolent-health
Evolent-health-inc
Citigroup
Health-care
Analyst-firm

In-Depth Examination Of 6 Analyst Recommendations For Evolent Health - Evolent Health (NYSE:EVH)

Mobile Medical Apps Market Poised For Remarkable Growth, To Surpass USD 43.4 Billion By 2032, Enabli

“Marketresearch.biz reports that the Mobile Medical Apps Market size is expected to be worth around USD 43.4 Bn by 2032 from USD 6.6 Bn in 2022, growing at a CAGR of 21.3% during the forecast period from 2023 to 2032.Overview of the Mobile Medical Apps MarketThe Mobile Medical Apps Market comprises applications deve.

Ukraine
Japan
China
New-york
United-states
South-africa
India
Saudi-arabia
Russia
Netherlands
South-korea
Germany

Evolent Health, Inc. (NYSE:EVH) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Evolent Health, Inc. (NYSE:EVH – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twelve analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 12-month price objective among […]

United-states
William-blair
Canaccord-genuity-group
Hedge-funds-weigh-in-on-evolent-health
Securities-inc
Group-wealth-management
Analyst-recommendations-for-evolent-health
Evolent-health
Evolent-health-stock-performance
Jpmorgan-chase-co
Evolent-health-inc
Tower-group

Canaccord Genuity Group Lowers Evolent Health (NYSE:EVH) Price Target to $44.00

Evolent Health (NYSE:EVH – Free Report) had its target price cut by Canaccord Genuity Group from $45.00 to $44.00 in a research report report published on Thursday, Benzinga reports. They currently have a buy rating on the technology company’s stock. A number of other equities analysts have also issued reports on the company. Oppenheimer assumed […]

United-states
Wellington
New-zealand-general
New-zealand
William-blair
News-ratings-for-evolent-health-daily
Barclays
Bellevue-group
Jpmorgan-chase-co
Evolent-health
Institutional-trading-of-evolent-health
Evolent-health-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.